GlassScriptPhysician profile
Kenneth C Hsiao
NPI 1265427975
$11,828.71
in general payments reported to CMS, 2019-2025
52 companies · $3,406 in 2025
The $3,406 reported for 2025 was more than what 88% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,192 · 2020: $705 · 2021: $1,264 · 2022: $823 · 2023: $1,906 · 2024: $2,533 · 2025: $3,406.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,919 · Travel and Lodging: $857 · Education: $68.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,919.43 |
| Travel and Lodging | $857.45 |
| Education | $68.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,170.78 | 2020-2024 | Axonics, Bulkamid |
| Janssen Biotech, INC. | $1,153.13 | 2020-2025 | Erleada, Carvykti, Rybrevant |
| Procept Biorobotics Corporation | $947.49 | 2019-2025 | Aquabeam Robotic System |
| Abbvie INC. | $774.33 | 2019-2025 | |
| Antares Pharma, INC. | $612.04 | 2022-2025 | Xyosted, Tlando, Nocdurna |
| Urogen Pharma, INC. | $592.77 | 2021-2025 | Jelmyto |
| Astellas Pharma US INC | $520.17 | 2020-2025 | Myrbetriq, Xtandi |
| Sumitomo Pharma America, INC. | $481.55 | 2023-2025 | Gemtesa |
| Pfizer INC. | $481.21 | 2019-2025 | |
| Angiodynamics, INC. | $419.48 | 2019-2025 | Nanoknife |
| Dendreon Pharmaceuticals LLC | $399.36 | 2019-2025 | Provenge |
| Allergan, INC. | $382.33 | 2019-2022 | |
| Teleflex LLC | $351.00 | 2021-2025 | Barrigel, Urolift |
| Coloplast Corp | $340.59 | 2021-2025 | Porges Coloplast |
| Boston Scientific Corporation | $321.66 | 2019-2024 | Spaceoar System, Spaceoar Vue System - 10ml |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $315.36 | 2021-2023 | Interstim |
| Ferring Pharmaceuticals INC. | $273.27 | 2019-2025 | Adstiladrin |
| Merck Sharp & Dohme LLC | $209.76 | 2022-2025 | Keytruda, Lynparza, Welireg |
| Kerecis Limited | $204.98 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Halozyme INC | $185.70 | 2023 | |
| Palette Life Sciences, INC. | $179.38 | 2021-2022 | |
| Accord Healthcare, INC. | $136.06 | 2024-2025 | |
| Myriad Genetic Laboratories, INC. | $127.85 | 2021-2024 | Prolaris, Myrisk |
| Ethicon US, LLC | $103.42 | 2023 | Certus 140 |
| Endo Pharmaceuticals INC. | $103.23 | 2019-2020 | |
| Verity Pharmaceuticals INC. | $100.29 | 2024-2025 | Trelstar, Tlando |
| Telix Pharmaceuticals | $86.55 | 2023 | Illuccix |
| Koelis INC. | $81.99 | 2023 | |
| Urovant Sciences INC | $69.30 | 2021-2022 | |
| Olympus America INC. | $67.25 | 2021-2024 | Itind System |
| Immunitybio, INC. | $65.11 | 2024 | |
| Bluewind Medical | $53.69 | 2024-2025 | Revi |
| C. R. Bard, INC. & Subsidiaries | $49.67 | 2019 | |
| Therapeuticsmd, INC. | $43.36 | 2019-2021 | |
| Biotissue Holdings INC. | $37.69 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $34.92 | 2025 | |
| Blue Earth Diagnostics | $34.91 | 2021-2022 | |
| Endo USA, INC. | $33.65 | 2024-2025 | Xiaflex |
| Myovant Sciences INC. | $25.81 | 2021 | |
| Heron Therapeutics, INC. | $23.33 | 2024 | Aponvie |
| Travere Therapeutics, INC. | $23.27 | 2022 | |
| Alexion Pharmaceuticals, INC. | $22.03 | 2022 | |
| Mimedx Group, INC. | $21.86 | 2024 | |
| Sun Pharmaceutical Industries INC. | $21.85 | 2024 | |
| Otsuka America Pharmaceutical, INC. | $21.21 | 2022 | |
| Profound Medical Corp. | $20.83 | 2025 | Tulsa-Pro |
| Laborie Medical Technologies Corp. | $19.15 | 2025 | |
| Sagent Pharmaceuticals | $19.00 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $16.77 | 2020 | |
| Srs Medical Systems, INC. | $16.34 | 2025 | Ct3000 Pro Base Unit, Urocuff-Dc Disposable, Single |
| Ambu INC. | $16.04 | 2025 | |
| 180 Medical, INC. | $15.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Hsiao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.